特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
315306

マルチプレックス診断の世界市場:2020年~2024年

Multiplexed Diagnostics Market by End-user and Geography - Forecast and Analysis 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.60円
マルチプレックス診断の世界市場:2020年~2024年
出版日: 2020年02月07日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のマルチプレックス診断市場は、2020年から2024年の予測期間中に15%のCAGRで成長し、93億5,000万米ドルの規模に達する見込みです。同市場は、慢性疾患および感染症の流行などが成長要因となっています。さらに、技術進歩により、市場成長も促進されると予想されています。

当レポートでは、世界のマルチプレックス診断市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の状況

  • 市場のエコシステム
  • 市場の特徴

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模(2019年)
  • 市場展望:予測(2019年~2024年)

第4章 ファイブフォース分析

  • ファイブフォースサマリー
  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第5章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション
  • 比較:エンドユーザーの配置別
  • 製薬・バイオテクノロジー企業-市場規模と予測2019-2024
  • ヘルスケアセンター-市場規模と予測2019年-2024
  • 学術機関とCRO-市場規模と予測2019-2024
  • 市場機会:エンドユーザー別

第6章 顧客情勢

  • 概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米-市場規模と予測2019-2024
  • 欧州-市場規模と予測2019-2024
  • アジア太平洋地域-市場規模と予測2019-2024
  • 南米-市場規模と予測2019-2024
  • 中東・アフリカ地域-市場規模と予測2019-2024
  • 主要国
  • 市場機会:地理学別

第8章 成長要因、課題、および動向

  • 数量的成長要因-需要主導型成長
  • 数量的成長要因-外部要因
  • 市場の課題
  • 市場動向

第9章 ベンダーの展望

  • ベンダー情勢
  • 情勢の革新

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

第11章 付録

  • 調査範囲
  • 米ドルの通貨換算レート
  • 調査方法
  • 略語のリスト
目次
Product Code: IRTNTR40652

Technavio has been monitoring the global multiplexed diagnostics market and it is poised to grow by USD 9.35 bn during 2020-2024, progressing at a CAGR of 15% during the forecast period. Our reports on global multiplexed diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by prevalence of chronic and infectious diseases.

In addition, technological advancements is anticipated to boost the growth of the global multiplexed diagnostics market as well.

Market Segmentation

Technavio's global multiplexed diagnostics market is segmented as below:

end-user

  • pharmaceutical and biotechnology companies
  • healthcare centers
  • academic institutes and CROs

Geographic segmentation

  • APAC
  • Europe
  • MEA
  • North America
  • South America

Key Trends for global multiplexed diagnostics market growth

This study identifies technological advancements as the prime reasons driving the global multiplexed diagnostics market growth during the next few years.

Prominent vendors in global multiplexed diagnostics market

We provide a detailed analysis of around 25 vendors operating in the global multiplexed diagnostics market, including some of the vendors such as Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
  • Healthcare centers - Market size and forecast 2019-2024
  • Academic institutes and CROs - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user placement
  • 24.Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ million)
  • 25.Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2024 (%)
  • 26.Healthcare centers - Market size and forecast 2019-2024 ($ million)
  • 27.Healthcare centers - Year-over-year growth 2019-2024 (%)
  • 28.Academic institutes and CROs - Market size and forecast 2019-2024 ($ million)
  • 29.Academic institutes and CROs - Year-over-year growth 2019-2024 (%)
  • 30. Market opportunity by End user
  • 31.Customer landscape
  • 32.Market share by geography 2019-2024 (%)
  • 33.Geographic comparison
  • 34.North America - Market size and forecast 2019-2024 ($ million)
  • 35.North America - Year-over-year growth 2019-2024 (%)
  • 36.Europe - Market size and forecast 2019-2024 ($ million)
  • 37.Europe - Year-over-year growth 2019-2024 (%)
  • 38.APAC - Market size and forecast 2019-2024 ($ million)
  • 39.APAC - Year-over-year growth 2019-2024 (%)
  • 40.South America - Market size and forecast 2019-2024 ($ million)
  • 41.South America - Year-over-year growth 2019-2024 (%)
  • 42.MEA - Market size and forecast 2019-2024 ($ million)
  • 43.MEA - Year-over-year growth 2019-2024 (%)
  • 44.Key leading countries
  • 45.Market opportunity by geography ($ million)
  • 46.Impact of drivers
  • 47.Impact of challenges
  • 48.Landscape disruption
  • 49.Industry risks
  • 50.Vendors covered
  • 51.Market positioning of vendors
  • 52.Agilent Technologies Inc. - Overview (1/3)
  • 53.Agilent Technologies Inc. - Overview (2/3)
  • 54.Agilent Technologies Inc. - Overview (3/3)
  • 55.Agilent Technologies Inc. - Business segments
  • 56.Agilent Technologies Inc. - Key offerings
  • 57.Agilent Technologies Inc. - Key customers
  • 58.Agilent Technologies Inc. - Segment focus
  • 59.Becton, Dickinson and Co. - Overview (1/3)
  • 60.Becton, Dickinson and Co. - Overview (2/3)
  • 61.Becton, Dickinson and Co. - Overview (3/3)
  • 62.Becton, Dickinson and Co. - Business segments
  • 63.Becton, Dickinson and Co. - Key offerings
  • 64.Becton, Dickinson and Co. - Key customers
  • 65.Becton, Dickinson and Co. - Segment focus
  • 66.bioMerieux SA - Overview (1/3)
  • 67.bioMerieux SA - Overview (2/3)
  • 68.bioMerieux SA - Overview (3/3)
  • 69.bioMerieux SA - Business segments
  • 70.bioMerieux SA - Key offerings
  • 71.bioMerieux SA - Key customers
  • 72.bioMerieux SA - Segment focus
  • 73.Bio-Rad Laboratories Inc. - Overview (1/3)
  • 74.Bio-Rad Laboratories Inc. - Overview (2/3)
  • 75.Bio-Rad Laboratories Inc. - Overview (3/3)
  • 76.Bio-Rad Laboratories Inc. - Business segments
  • 77.Bio-Rad Laboratories Inc. - Key offerings
  • 78.Bio-Rad Laboratories Inc. - Key customers
  • 79.Bio-Rad Laboratories Inc. - Segment focus
  • 80.Illumina Inc. - Overview (1/3)
  • 81.Illumina Inc. - Overview (2/3)
  • 82.Illumina Inc. - Overview (3/3)
  • 83.Illumina Inc. - Business segments
  • 84.Illumina Inc. - Key offerings
  • 85.Illumina Inc. - Key customers
  • 86.Illumina Inc. - Segment focus
  • 87.Merck KGaA - Overview (1/3)
  • 88.Merck KGaA - Overview (2/3)
  • 89.Merck KGaA - Overview (3/3)
  • 90.Merck KGaA - Business segments
  • 91.Merck KGaA - Key offerings
  • 92.Merck KGaA - Key customers
  • 93.Merck KGaA - Segment focus
  • 94.QIAGEN NV - Overview (1/3)
  • 95.QIAGEN NV - Overview (2/3)
  • 96.QIAGEN NV - Overview (3/3)
  • 97.QIAGEN NV - Business segments
  • 98.QIAGEN NV - Key offerings
  • 99.QIAGEN NV - Key customers
  • 100.QIAGEN NV - Segment focus
  • 101.F. Hoffmann-La Roche Ltd. - Overview (1/3)
  • 102.F. Hoffmann-La Roche Ltd. - Overview (2/3)
  • 103.F. Hoffmann-La Roche Ltd. - Overview (3/3)
  • 104.F. Hoffmann-La Roche Ltd. - Business segments
  • 105.F. Hoffmann-La Roche Ltd. - Key offerings
  • 106.F. Hoffmann-La Roche Ltd. - Key customers
  • 107.F. Hoffmann-La Roche Ltd. - Segment focus
  • 108.Siemens AG - Overview (1/3)
  • 109.Siemens AG - Overview (2/3)
  • 110.Siemens AG - Overview (3/3)
  • 111.Siemens AG - Business segments
  • 112.Siemens AG - Key offerings
  • 113.Siemens AG - Key customers
  • 114.Siemens AG - Segment focus
  • 115.Thermo Fisher Scientific Inc. - Overview (1/3)
  • 116.Thermo Fisher Scientific Inc. - Overview (2/3)
  • 117.Thermo Fisher Scientific Inc. - Overview (3/3)
  • 118.Thermo Fisher Scientific Inc. - Business segments
  • 119.Thermo Fisher Scientific Inc. - Key offerings
  • 120.Thermo Fisher Scientific Inc. - Key customers
  • 121.Thermo Fisher Scientific Inc. - Segment focus
  • 122.Currency conversion rates for US$
  • 123.Research Methodology
  • 124.Validation techniques employed for market sizing
  • 125.Information sources
  • 126.List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.